세계의 규제 승인 앱 시장에 대해 조사 분석했으며, 각 지역별 시장 규모, 주요 동향, 혁신적인 제품 및 기술, 경쟁 구도 등의 정보를 전해드립니다.
시장 모델의 주요 내용은 다음과 같습니다.
이미 출시된 규제 승인 앱과 진화하는 경쟁 구도
세계, 지역, 국가 단위의 각 시장 인사이트
의료제도의 개요를 포함한 진정한 전체 그림을 파악하여 시장에 대한 이해를 돕습니다. 또한, 시장 진입 부문에서는 상환 정책 및 규제 환경에 대한 정보를 제공하여 시장 역학에 대한 심층적인 이해를 돕습니다.
대상 기업
Regulatory Approved Apps Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Digital Health therapeutic area.
Regulatory Approved Apps refers to mobile applications, usually installed on a Smart Phone or Tablet computer, that have been approved by the relevant national regulator to act as a medical device.
Regulatory Approved Apps are specifically developed for the iOS or android mobile phone platforms. Many require a prescription to access and qualify as digital therapeutics. Regulated apps are a relatively new market being categorized as medical devices. There is a large difference in the quality of apps available as wellness aids and those that have met the regulatory burden to meet regulatory approval. There are many different regulatory bodies that may or may not yet recognize mobile apps as having medical device capabilities. While almost any condition can benefit in some way from a regulated app.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with value, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insights offer context for quantitative data.
Key Inclusions of the market model are:
Currently marketed Regulatory Approved Apps and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered : Akili Interactive Labs, Inc., Abbott Laboratories, Johnson & Johnson Medical GmbH, Medtronic, Inc, Otsuka Pharmaceutical Co., Ltd., Stryker Corp, Dexcom Inc, Livongo Health Inc, Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to: